当前位置: 首页 >> 检索结果
共有 3909 条符合本次的查询结果, 用时 9.1846218 秒

3521. Heart failure and abnormal ventricular function. Pathophysiology and clinical correlation (Part 2).

作者: C Shub.
来源: Chest. 1989年96卷4期906-14页

3522. Treatment for primary pulmonary hypertension. Back to the future.

作者: J E McManigle.;M F Tenholder.
来源: Chest. 1989年96卷4期900-5页

3523. New concepts in the pathogenesis and modalities of the chemoprophylaxis of native valve endocarditis.

作者: A S Bayer.
来源: Chest. 1989年96卷4期893-9页
Recommendations for the prophylaxis of BE have changed over the last 10-15 years toward fewer-dose and oral regimens. An advisory committee of the AHA is currently formulating new guidelines for the prevention of BE that will likely be promulgated in 1990 or 1991. It is anticipated that such recommendations will feature the new information on MVP and focus on oral prophylactic regimens.

3524. Mechanisms of multiple nonpulmonary organ failure in ARDS.

作者: P M Dorinsky.;J E Gadek.
来源: Chest. 1989年96卷4期885-92页

3525. Bronchoscopic localization and treatment of occult lung cancer.

作者: E S Edell.;D A Cortese.
来源: Chest. 1989年96卷4期919-21页
The flexible fiberoptic bronchoscope is currently the standard tool for localization of radiographically occult carcinomas of the tracheobronchial tree. It allows direct inspection of proximal airways and can establish the location of most occult lung cancers. A small percentage of patients present with bronchoscopically as well as radiographically occult carcinoma, particularly challenging because definitive localizations is required before a therapeutic plan can be outlined. Selective cytologic brushing of each lobar segment, taking random biopsy specimens, has been used to assist in localization of these early cancers. Recently, fluorescent compounds have been used to assist in localizing early lung cancers and in the treatment of radiographically occult carcinoma. We review the current methods of bronchoscopic localization and treatment of radiographically occult lung cancer.

3526. Occupational pollution.

作者: M R Becklake.
来源: Chest. 1989年96卷3 Suppl期372S-378S页

3527. Domestic pollution as a factor causing respiratory health effects.

作者: J S Boleij.;B Brunekreef.
来源: Chest. 1989年96卷3 Suppl期368S-372S页

3528. Atmospheric pollution.

作者: R E Waller.
来源: Chest. 1989年96卷3 Suppl期363S-368S页

3529. Acute respiratory infections.

作者: J R Colley.;D L Miller.
来源: Chest. 1989年96卷3 Suppl期355S-360S页

3530. Chronic airways disease. The smoking component.

作者: J Crofton.;R Masironi.
来源: Chest. 1989年96卷3 Suppl期349S-355S页

3531. Epidemiologic studies of chronic respiratory diseases in some regions of China.

作者: B Y Yan.
来源: Chest. 1989年96卷3 Suppl期339S-343S页

3532. Asthma and chronic bronchitis in Africa. Evidence from epidemiologic studies.

作者: P Chaulet.
来源: Chest. 1989年96卷3 Suppl期334S-339S页

3533. Chronic airways disease in the United States. Trends and determinants.

作者: M W Higgins.
来源: Chest. 1989年96卷3 Suppl期328S-334S页

3534. Clinical implications of nuclear magnetic resonance lung research.

作者: A G Cutillo.;A H Morris.;D C Ailion.;C H Durney.
来源: Chest. 1989年96卷3期643-52页

3535. Are AIDS patients at risk for pulmonary alveolar proteinosis?

作者: R H Israel.;C R Magnussen.
来源: Chest. 1989年96卷3期641-2页

3536. Heart failure and abnormal ventricular function. Pathophysiology and clinical correlation (Part 1).

作者: C Shub.
来源: Chest. 1989年96卷3期636-40页

3537. Dyspnea in pregnancy.

作者: M F Tenholder.;J E South-Paul.
来源: Chest. 1989年96卷2期381-8页

3538. Calcium channel blockers as inhibitors of drug metabolism.

作者: B A Hunt.;T H Self.;R L Lalonde.;M B Bottorff.
来源: Chest. 1989年96卷2期393-9页

3539. Nutritional support in the critical care setting (Part 2).

作者: R Berger.;L Adams.
来源: Chest. 1989年96卷2期372-80页

3540. Therapeutic approach to malignant mesothelioma.

作者: J Aisner.
来源: Chest. 1989年96卷1 Suppl期95S-97S页
共有 3909 条符合本次的查询结果, 用时 9.1846218 秒